Demyelinizing Neurological Disease after Treatment with Tumor Necrosis Factor-α Antagonists
نویسندگان
چکیده
منابع مشابه
Demyelinizing Neurological Disease after Treatment with Tumor Necrosis Factor-α Antagonists
PURPOSE Demyelinizing neurological disease is a rare complication after treatment with tumor necrosis factor (TNF)α antagonists. We report on a case of multiple sclerosis after TNFα antagonist treatment and discuss its differential diagnosis. METHODS This is an observational case study. RESULTS A 48-year-old male was referred to Ophthalmology in January 2015 for an absolute scotoma in the s...
متن کاملNontuberculous Mycobacterium Infection and Tumor Necrosis Factor-α Antagonists
To the Editor: Mycobacterium haemophilum is an aerobic, slowgrowing microorganism with optimal growth at 30°C to 32°C. It has a unique requirement for ferric iron–containing compounds (1), from which it acquired its name (i.e., haemophilum). Infections with M. haemophilum are rare, but cervicofacial lymphadenitis caused by M. haemophilum has been described in children (2). Besides cervicofacial...
متن کاملSkin lesions and treatment with tumor necrosis factor alpha antagonists.
The efficacy shown by biological therapy with tumor necrosis factor (TNF) antagonists has led in the recent years to its increased and extended use in different inflammatory arthopathies. Initially, safety studies of these drugs were mainly focused on the risk of infection and the development of malignancies. Recently, several cases of skin lesions induced by anti-TNF drugs have been reported w...
متن کاملAnorectal stenosis after treatment with tumor necrosis factor α antibodies: a case series
INTRODUCTION We identified three patients who developed anorectal stenosis after successful treatment with anti-tumor necrosis factor alpha (anti-TNF-alpha) agents. CASE PRESENTATION Two patients, a 24-year-old Irish Caucasian man and a 64-year-old Irish Caucasian woman, developed symptoms attributable to anorectal stenosis four to six weeks after treatment. A further patient, a 25-year-old I...
متن کاملDevelopment of Rheumatoid Nodules after Anti-Tumor Necrosis Factor-α Treatment with Adalimumab for Rheumatoid Arthritis
402 Ann Dermatol Received March 23, 2015, Revised June 22, 2015, Accepted for publication June 24, 2015 Corresponding author: Dae Suk Kim, Department of Dermatology, Severance Hospital, Cutaneous Biology Research Institute, Yonsei University College of Medicine, 50-1 Yonsei-ro, Seodaemun-gu, Seoul 03722, Korea. Tel: 82-2-2228-2080, Fax: 82-2-393-9157, E-mail: [email protected] This is an Open Acces...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Case Reports in Ophthalmology
سال: 2016
ISSN: 1663-2699
DOI: 10.1159/000447086